Micro Labs Telmisartan Tablets Recall: Failed Stability Specifications

Take action

Contact the company & request your remedy

Recalling firmMicro Labs LimitedPlot# S - 155, & N1 Phase Iii & Phase Iv; Verna Ind Estate Road · Verna, N/A N/A

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Micro Labs is recalling 40mg Telmisartan tablets (Rx only) because they failed stability tests. This means the tablets may not be as effective as intended, but it does not pose an immediate safety risk.

Why it’s dangerous

The tablets failed stability tests for blend uniformity, meaning the active ingredients may not mix properly. This could lead to inconsistent dosing, but it does not cause immediate harm or injury.

Who’s affected

Prescription patients who have received the recalled lot numbers SFBG024 or SFBG025 from Micro Labs Limited. Patients using these specific tablets are most at risk of reduced effectiveness.

How to tell if you have this one

Check for lot numbers SFBG024 or SFBG025 on the bottle. The product was manufactured in India and sold by Micro Labs USA Inc. in the US with an expiration date of May 31, 2024.

Brand
Micro Labs
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Lot Number
Look for lot numbers SFBG024 or SFBG025 on the bottle label.

✎ GovInfoNow

Questions people ask

Why is this product being recalled?

The tablets failed stability tests for blend uniformity, which may affect their effectiveness.

What should I do if I have the recalled product?

Contact Micro Labs USA Inc. for details on affected lots and next steps.

Is there a risk of injury from this product?

No, the recall is for effectiveness issues only, not safety risks.

Take action

Contact Micro Labs

We’ve drafted a message you can send Micro Labs to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0388-2024 — Micro Labs Micro Labs

Hello,

I own a Micro Labs that is covered by recall D-0388-2024 from Micro Labs.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0388-2024 (February 9, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0388-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Micro Labs Limited recalls Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA,

Lower-risk recall